BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 18021115)

  • 1. HIV vaccine trials: reconsidering the therapeutic misconception and the question of what constitutes trial related injuries.
    Schüklenk U; Ashcroft R
    Dev World Bioeth; 2007 Dec; 7(3):ii-iv. PubMed ID: 18021115
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to 'HIV vaccine trials: reconsidering the therapeutic misconception and the question of what constitutes trial-related injuries'.
    Slack C; Stobie M
    Dev World Bioeth; 2008 Aug; 8(2):159-61. PubMed ID: 18717887
    [No Abstract]   [Full Text] [Related]  

  • 3. AIDS: bioethics and public policy.
    Schuklenk U
    New Rev Bioeth; 2003 Nov; 1(1):127-44. PubMed ID: 15706680
    [No Abstract]   [Full Text] [Related]  

  • 4. Microbicide research in developing countries: have we given the ethical concerns due consideration?
    Moodley K
    BMC Med Ethics; 2007 Sep; 8():10. PubMed ID: 17877834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moving toward assured access to treatment in microbicide trials. Global Campaign for Microbicides.
    Forbes A
    PLoS Med; 2006 Jul; 3(7):e153. PubMed ID: 16805648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical issues in HIV vaccine trials in South Africa.
    Slack C; Lindegger G; Vardas E; Richter L; Strode A; Wassenaar D
    S Afr J Sci; 2000 Jun; 96():291-5. PubMed ID: 11863014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provision of HIV treatment in HIV preventive vaccine trials: a developing country perspective.
    Slack C; Stobie M; Milford C; Lindegger G; Wassenaar D; Strode A; Ijsselmuiden C
    Soc Sci Med; 2005 Mar; 60(6):1197-208. PubMed ID: 15626517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stakeholder perspectives on ethical challenges in HIV vaccine trials in South Africa.
    Essack Z; Koen J; Barsdorf N; Slack C; Quayle M; Milford C; Lindegger G; Ranchod C; Mukuka R
    Dev World Bioeth; 2010 Apr; 10(1):11-21. PubMed ID: 19459900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-five years of therapeutic misconception.
    Miller FG
    Hastings Cent Rep; 2008; 38(2):6; author reply 6-7. PubMed ID: 18457218
    [No Abstract]   [Full Text] [Related]  

  • 10. Starting from scratch: program development and lessons learned from HIV vaccine trial counseling in Thailand.
    Thapinta D; Jenkins RA
    Contemp Clin Trials; 2007 Jul; 28(4):409-22. PubMed ID: 17196444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sharing the benefits of HIV/AIDS research with resource-poor countries: AZT for pregnant women in Africa?
    Needham DM
    Hum Health Care Int; 1997; 13(3):E11. PubMed ID: 14986616
    [No Abstract]   [Full Text] [Related]  

  • 12. Social and behavioral aspects of child and adolescent participation in HIV vaccine trials.
    Swartz L; Kagee A; Kafaar Z; Smit J; Bhana A; Gray G; Lesch A; Lindegger G; Milford C; Richter L; Seedat S; Skhosana N; Stein DJ
    J Int Assoc Physicians AIDS Care (Chic); 2005 Dec; 4(4):89-92. PubMed ID: 16533797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing social risks prior to commencement of a clinical trial: due diligence or ethical inflation?
    Burris S; Davis C
    Am J Bioeth; 2009 Nov; 9(11):48-54. PubMed ID: 19882460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.
    Mamotte N; Wassenaar D; Koen J; Essack Z
    BMC Med Ethics; 2010 Mar; 11():3. PubMed ID: 20211030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing therapies less effective than the best current standard: ethical beliefs in an international sample of researchers.
    Kent DM; Mwamburi M; Cash RA; Rabin TL; Bennish ML
    Am J Bioeth; 2003; 3(2):W11. PubMed ID: 14635629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of access to HIV treatment.
    Galatowitsch P; Siegfried N
    Science; 2006 Dec; 314(5805):1540-1; author reply 1540-1. PubMed ID: 17158305
    [No Abstract]   [Full Text] [Related]  

  • 17. The challenge of assuring continued post-trial access to beneficial treatment.
    Grady C
    Yale J Health Policy Law Ethics; 2005; 5(1):425-35. PubMed ID: 15742586
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trials as treatment option: bioethics and health care disparities in substance dependency.
    Timmermans S; McKay T
    Soc Sci Med; 2009 Dec; 69(12):1784-90. PubMed ID: 19819059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The quality of informed consent in a clinical research study in Thailand.
    Pace C; Emanuel EJ; Chuenyam T; Duncombe C; Bebchuk JD; Wendler D; Tavel JA; McNay LA; Phanuphak P; Forster HP; Grady C
    IRB; 2005; 27(1):9-17. PubMed ID: 15835065
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV vaccine trials: critical issues in informed consent.
    Lindegger G; Richter LM
    S Afr J Sci; 2000 Jun; 96():313-7. PubMed ID: 15739286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.